AVACTA GROUP PLC
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
AVCT | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYYW9G87
- LEI:
- 2138009U3EG31OPMGH36
- Country:
- United Kingdom
- Address:
- UNIT 20 ASH WAY, THORP ARCH ESTATE, LS23 7FA WETHERBY
- Website:
- https://avacta.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Avacta Group PLC is a clinical-stage life sciences company focused on developing innovative cancer therapies through its proprietary pre|CISION® platform. This peptide drug conjugate (PDC) technology is designed to deliver anti-tumor payloads directly to the tumor, aiming to improve the safety and efficacy of potent cancer drugs and expand their therapeutic use. The company's pipeline includes targeted oncology drugs, with a key focus on advancing its assets through clinical trials and strategic partnerships. While historically involved in diagnostics, Avacta is increasingly concentrating its resources on its core therapeutics division.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-03 09:45 |
Share Issue/Capital Change
Completion of Placing and TVR
|
English | 15.7 KB | ||
| 2025-10-27 18:39 |
Share Issue/Capital Change
Block Listing Six Monthly Return
|
English | 27.8 KB | ||
| 2025-10-20 08:01 |
Share Issue/Capital Change
Equity fundraise of £16 million
|
English | 45.3 KB | ||
| 2025-10-20 08:00 |
Regulatory News Service
Avacta Presents Phase 1a Data for Faridoxorubicin
|
English | 30.5 KB | ||
| 2025-10-13 08:00 |
Regulatory News Service
Avacta to present data at EORTC-NCI-AACR
|
English | 22.7 KB | ||
| 2025-09-15 08:00 |
Report Publication Announcement
Notice of Interim Results
|
English | 17.8 KB | ||
| 2025-09-09 08:00 |
Regulatory News Service
Shortlisted for AIM Awards Technology of the Year
|
English | 15.2 KB | ||
| 2025-07-30 08:00 |
Earnings Release
Avacta to Present at ESMO Congress
|
English | 17.3 KB | ||
| 2025-07-28 08:48 |
M&A Activity
Agreement to Sell Coris Bioconcept SRL
|
English | 17.8 KB | ||
| 2025-07-21 08:00 |
Capital/Financing Update
Payment of Convertible Bond Installment
|
English | 16.0 KB | ||
| 2025-07-17 08:00 |
Share Issue/Capital Change
Equity fundraise of £3.25 million
|
English | 42.4 KB | ||
| 2025-07-02 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 29.4 KB | ||
| 2025-07-02 08:00 |
Regulatory News Service
Q2 2025 Business Update
|
English | 25.6 KB | ||
| 2025-06-06 08:00 |
Earnings Release
Preliminary Full Year 2024 Results
|
English | 512.2 KB | ||
| 2025-05-28 08:00 |
Board/Management Information
Board appointments
|
English | 30.9 KB |
Automate Your Workflow. Get a real-time feed of all AVACTA GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AVACTA GROUP PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AVACTA GROUP PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
